06.20.23 -- The Need — And Opportunity — To Develop Broad-Spectrum Antivirals

Describing the pore of a size exclusion chromatography resin with a single number is an oversimplification. The formation of pores is dependent on complex combinations of many parameters.

Drug lipophilicity is a core property that contributes to drug solubility, permeability, metabolic disposition, and other key properties. Investigate how drug lipophilicity has changed with some data.

A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need.

There was a short time frame of only seven weeks to complete assay optimization and conduct pre-validation studies within the confines of USP<621>.

Lonza Pharma & Biotech’s Jonas Mueller and Nikolay Krumov answer attendee questions from a recent webinar about the pros and cons of soluble and insoluble processes as well as other related topics.

Late-phase development requires a holistic development strategy driven by a well-defined target product profile. Here's an overview of the complex path to a successful product launch.